Patent ID: 9145248
Filing Date: 2015-09-29
Classification: A61J,B31B,B65D,Y10T

Abstract:
1. A single-dose packaging for transdermal therapeutic systems or forms of administration in foil form, in the form of a tear-open sealed-edge pouch including a product receiving region enclosing a packaged product and a continuous sealing area or sealing seam completely surrounding the product receiving region and being non-peelable, the tear-open sealed-edge pouch comprising first and second packaging material elements, which are arranged with the first packaging material element lying on top of the second packaging material element and respectively forming the upper side and underside of the tear-open sealed-edge pouch which contains the product, at least one layer of the packaging material elements including a metal layer and at least one of the first and second packaging material elements being a foil laminate having an at least three-layered structure including an outer layer, a middle layer and an inner layer, and the outer layer of the at least three-layered foil laminate having a minimum resistance to tearing of 30 newtons, the outer layer having at least one line of weakness, not touching the peripheral edge of the packaging, congruently on the upper side and underside of this outer layer and the at least one line of weakness having a reduced resistance to tearing for the opening of the packaging, the at least one line of weakness collinear with a bending line, the product receiving region has a protuberance reaching into the sealing area, the at least one line of weakness runs both through the sealing area and through the product receiving region in the protuberance, the protuberance not running over the entire length of one side of the product receiving region, whereby the packaging is first bent along the bending line in order to expose the beginning of the at least one line of weakness which the packaging can then be torn open and which predetermines the tearing path.